Related Experiment Videos
[Target controlled infusion (TCI)--status and clinical perspectives]
S Schraag1, J Flaschar, M Georgieff
1Universitätsklinik für Anästhesiologie der Universität Ulm. stefanschraag@compuserve.com
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|February 26, 2000
Summary
Target Controlled Infusion (TCI) systems, like the Diprifusor for propofol, are revolutionizing intravenous anesthesia. This technology is moving from research to routine practice, enhancing peri-operative care.
Area of Science:
- Anesthesiology
- Pharmacokinetics
- Medical Technology
Context:
- Target Controlled Infusion (TCI) has significantly advanced intravenous anesthesia.
- The introduction of the Diprifusor system for propofol marked a key development in computer-assisted drug delivery.
- TCI is transitioning from a specialized research tool to a standard technique in anesthesia practice.
Purpose:
- To review the pharmacokinetic principles behind TCI development.
- To discuss preliminary clinical experiences and performance of TCI devices.
- To highlight potential technical challenges in routine TCI use.
Summary:
- This review updates on the pharmacokinetic basis and clinical application of TCI in anesthesia.
- It covers the performance, accuracy, and potential pitfalls of TCI devices.
- TCI systems are becoming integral to routine anesthesia and peri-operative drug administration.
Impact:
- TCI technology is enhancing the precision and safety of intravenous anesthesia.
- It facilitates new applications in peri-operative care and drug delivery.
- TCI systems are valuable research tools for studying drug interactions and developing novel control techniques.